Vanguard Morningstar Value ETF

最新新闻

• LifeSci Capital Maintains VTv Therapeutics(VTVT.US) With Buy Rating, Maintains Target Price $60
  Market Newswire · 2026/10/6
• 评级变动
  BTIG Maintains VTv Therapeutics(VTVT.US) With Buy Rating, Raises Target Price to $57
  Market Newswire · 2026/7/16
• 评级变动
  A Quick Look at Today's Ratings for VTv Therapeutics(VTVT.US), With a Forecast Between $45 to $58
  Market Newswire · 2026/5/14
• 评级变动
  H.C. Wainwright Maintains VTv Therapeutics(VTVT.US) With Buy Rating, Maintains Target Price $45
  Market Newswire · 2026/5/27
• 评级变动
  A. G. P. Maintains VTv Therapeutics(VTVT.US) With Buy Rating, Maintains Target Price $55
  Market Newswire · 2026/5/14
• 评级变动
  Rodman & Renshaw Initiates VTv Therapeutics(VTVT.US) With Buy Rating, Announces Target Price $67
  Market Newswire · 2026/6/30
• 公司公告
  4: vTv Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BAKER BROS. ADVISORS LP
  SEC · 2026/6/30
• H.C. Wainwright Maintains VTv Therapeutics(VTVT.US) With Buy Rating, Maintains Target Price $42
  Market Newswire · 2026/9/22
• BTIG Maintains VTv Therapeutics(VTVT.US) With Buy Rating, Maintains Target Price $57
  Market Newswire · 2026/10/15
• 公司公告
  vTv Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Phillips Anne M.
  SEC · 2025/6/13
• 评级变动
  TD Cowen Maintains VTv Therapeutics(VTVT.US) With Buy Rating, Maintains Target Price $67
  Market Newswire · 2026/5/15
• 评级变动
  H.C. Wainwright Maintains VTv Therapeutics(VTVT.US) With Buy Rating, Cuts Target Price to $42
  Market Newswire · 2026/8/7
• 公司公告
  4: vTv Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Phillips Anne M.
  SEC · 2026/6/30
• LifeSci Capital Initiates VTv Therapeutics(VTVT.US) With Buy Rating, Announces Target Price $60
  Market Newswire · 2026/9/2
• 评级变动
  H.C. Wainwright Sticks to Their Buy Rating for VTv Therapeutics (VTVT)
  TipRanks · 2026/5/27
• 公司公告
  vTv Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BAKER BROS. ADVISORS LP
  SEC · 2025/9/6
• 公司公告
  vTv Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BAKER BROS. ADVISORS LP
  SEC · 2025/6/13
• 评级变动
  Evercore Initiates VTv Therapeutics(VTVT.US) With Buy Rating, Announces Target Price $44
  Market Newswire · 2026/3/13
• Roth MKM Maintains VTv Therapeutics(VTVT.US) With Buy Rating, Maintains Target Price $58
  Market Newswire · 2026/10/6
• 评级变动
  Analysts Offer Insights on NA Companies: VTv Therapeutics (VTVT), TripAdvisor (TRIP) and Caris Life Sciences, Inc. (CAI)
  TipRanks · 2026/8/7
• H.C. Wainwright Sticks to Its Buy Rating for VTv Therapeutics (VTVT)
  TipRanks · 2026/9/22
• 评级变动
  BTIG Maintains VTv Therapeutics(VTVT.US) With Buy Rating, Maintains Target Price $57
  Market Newswire · 2026/8/7
• Roth MKM Maintains VTv Therapeutics(VTVT.US) With Buy Rating, Maintains Target Price $58
  Market Newswire · 2026/8/7

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。